Vanguard Capital Management’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
Other funds holding VOR
Vanguard Capital Management's VOR Position: Q3 2026 in Review
Vanguard Capital Management reduced its Vor Biopharma (VOR) stake by 2.3% in Q3 2026, selling an estimated $1.04M and leaving 2,035,477 shares worth $38.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2033.
Vanguard Capital Management first reported a position in VOR in Q1 2026 and has held it in 3 quarters since. 156 funds tracked by Wall St. Rank hold VOR as of Q3 2026.
- Vanguard Capital Management held 2,035,477 shares of Vor Biopharma worth $38.8M as of Q3 2026.
- Vanguard Capital Management sold 48,851 Vor Biopharma shares in Q3 2026, an estimated $1.04M.
- Vor Biopharma made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2033 holding.
- Vanguard Capital Management first reported a position in Vor Biopharma in Q1 2026 and has held it in 3 quarters since.
- 156 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.